Title:
インジルビンのナノ微粒子、その誘導体およびそれらを作製しかつ利用する方法
Document Type and Number:
Japanese Patent JP6382187
Kind Code:
B2
Abstract:
The disclosure provides nanoparticles of indirubin and methods of making and using these particles for the treatment of cancer, neurodegenerative disorders and inflammatory diseases. The effective average particle size of the nanoparticles is less than 2000 nm.
Inventors:
Woo, bottle
Application Number:
JP2015518599A
Publication Date:
August 29, 2018
Filing Date:
June 21, 2013
Export Citation:
Assignee:
Phosphorex, Incorporated
International Classes:
A61K31/404; A61K9/10; A61K45/00; A61K47/34; A61P25/00; A61P29/00; A61P35/00; A61P43/00
Domestic Patent References:
| JP2010529050A | ||||
| JP2008521931A | ||||
| JP2007522114A | ||||
| JP2009292810A | ||||
| JP2008545752A | ||||
| JP2011503044A |
Foreign References:
| CN102228433A |
Other References:
Clin Cancer Res,2007年 1月 1日,Vol.13, No.1,p253-259
Chinese Journal of Pharmaceuticals,2006年,Vol.37, No.1,p23-25
Chinese Journal of Pharmaceuticals,2006年,Vol.37, No.1,p23-25
Attorney, Agent or Firm:
Yusuke Hiraki
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Naoko Kikuta
Nobuto Oki
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Naoko Kikuta
Nobuto Oki